Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intranasal dexmedetomidine for postoperative cognitive function in elderly laparoscopic surgery
ChiCTR2600120827Phase 3Recruiting
- Sponsor
- The First Affiliated Hospital of Dalian Medical University
- Start
- Mar 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of dexmedetomidine in post-operative cognitive decline (POCD), postoperative pain and postoperative nausea and vomiting (PONV) (4 arms), sponsored by The First Affiliated Hospital of Dalian Medical University. Primary endpoint: Incidence of postoperative cognitive dysfunction (POCD). Started Mar 2026; status: recruiting.
02
Drugs
dexmedetomidine
03
Conditions
post-operative cognitive decline (POCD)postoperative painpostoperative nausea and vomiting (PONV)
Beyond the preview
Go deeper on ChiCTR2600120827.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2600120827.